The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary

The aim of our study was to examine the involvement of renin-angiotensin system (RAS) in estrogen-induced lactotropes proliferation and vascular endothelial growth factor (VEGF) expression in rat pituitary. The study was performed on Fisher 344 rats underwent 8-day treatment with diethylstilboestrol...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanna Lawnicka, Dorota Ptasinska-Wnuk, Slawomir Mucha, Jolanta Kunert-Radek, Marek Pawlikowski, Henryk Stepien
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/2012/358102
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561726246092800
author Hanna Lawnicka
Dorota Ptasinska-Wnuk
Slawomir Mucha
Jolanta Kunert-Radek
Marek Pawlikowski
Henryk Stepien
author_facet Hanna Lawnicka
Dorota Ptasinska-Wnuk
Slawomir Mucha
Jolanta Kunert-Radek
Marek Pawlikowski
Henryk Stepien
author_sort Hanna Lawnicka
collection DOAJ
description The aim of our study was to examine the involvement of renin-angiotensin system (RAS) in estrogen-induced lactotropes proliferation and vascular endothelial growth factor (VEGF) expression in rat pituitary. The study was performed on Fisher 344 rats underwent 8-day treatment with diethylstilboestrol (DES). The proliferation index (PCNA) and VEGF expression in pituitary sections were estimated using immunohistochemical methods. Treatment with DES increased the number of PCNA-positive cells, VEGF-positive cells, and VEGF-positive blood vessels in pituitary. Stimulatory effect of estrogen on cell proliferation and VEGF expression in blood vessels was attenuated by losartan, PD123319, and captopril. VEGF immunoreactivity in pituitary cells of DES-treated rats was decreased by AT1 antagonist and not changed by AT2 blocker and ACE inhibitor. Our findings suggest the involvement of RAS in DES-induced cell proliferation and VEGF expression in pituitary. Both the AT1 and AT2 receptors appear to mediate the estrogen-dependent mitogenic and proangiogenic effects in rat pituitary.
format Article
id doaj-art-a44c658c1b464701b12eac94c1737324
institution Kabale University
issn 1537-744X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-a44c658c1b464701b12eac94c17373242025-02-03T01:24:24ZengWileyThe Scientific World Journal1537-744X2012-01-01201210.1100/2012/358102358102The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior PituitaryHanna Lawnicka0Dorota Ptasinska-Wnuk1Slawomir Mucha2Jolanta Kunert-Radek3Marek Pawlikowski4Henryk Stepien5Department of Immunoendocrinology, Medical University of Lodz, Dr. Sterling 3 Street, 91-425 Lodz, PolandDepartment of Endocrinology, The County Hospital of Kutno, 52 Kosciuszki Street, 99-300 Kutno, PolandClinic of Endocrinology, Medical University of Lodz, Dr. Sterling 3 Street, 91-425 Lodz, PolandClinic of Endocrinology, Medical University of Lodz, Dr. Sterling 3 Street, 91-425 Lodz, PolandDepartment of Immunoendocrinology, Medical University of Lodz, Dr. Sterling 3 Street, 91-425 Lodz, PolandDepartment of Immunoendocrinology, Medical University of Lodz, Dr. Sterling 3 Street, 91-425 Lodz, PolandThe aim of our study was to examine the involvement of renin-angiotensin system (RAS) in estrogen-induced lactotropes proliferation and vascular endothelial growth factor (VEGF) expression in rat pituitary. The study was performed on Fisher 344 rats underwent 8-day treatment with diethylstilboestrol (DES). The proliferation index (PCNA) and VEGF expression in pituitary sections were estimated using immunohistochemical methods. Treatment with DES increased the number of PCNA-positive cells, VEGF-positive cells, and VEGF-positive blood vessels in pituitary. Stimulatory effect of estrogen on cell proliferation and VEGF expression in blood vessels was attenuated by losartan, PD123319, and captopril. VEGF immunoreactivity in pituitary cells of DES-treated rats was decreased by AT1 antagonist and not changed by AT2 blocker and ACE inhibitor. Our findings suggest the involvement of RAS in DES-induced cell proliferation and VEGF expression in pituitary. Both the AT1 and AT2 receptors appear to mediate the estrogen-dependent mitogenic and proangiogenic effects in rat pituitary.http://dx.doi.org/10.1100/2012/358102
spellingShingle Hanna Lawnicka
Dorota Ptasinska-Wnuk
Slawomir Mucha
Jolanta Kunert-Radek
Marek Pawlikowski
Henryk Stepien
The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
The Scientific World Journal
title The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_full The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_fullStr The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_full_unstemmed The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_short The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_sort involvement of angiotensin type 1 and type 2 receptors in estrogen induced cell proliferation and vascular endothelial growth factor expression in the rat anterior pituitary
url http://dx.doi.org/10.1100/2012/358102
work_keys_str_mv AT hannalawnicka theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT dorotaptasinskawnuk theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT slawomirmucha theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT jolantakunertradek theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT marekpawlikowski theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT henrykstepien theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT hannalawnicka involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT dorotaptasinskawnuk involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT slawomirmucha involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT jolantakunertradek involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT marekpawlikowski involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT henrykstepien involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary